Efficacy of Er: YSGG Laser in Treatment of Peri-implantitis
Primary Purpose
Peri-Implantitis
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Er: YSGG laser
no therapy
Sponsored by
About this trial
This is an interventional treatment trial for Peri-Implantitis focused on measuring Er: YSGG laser therapy, Peri-Implantitis
Eligibility Criteria
Inclusion Criteria:
- Sex: female or male.
- Age: 25 - 55 years.
- Medically controlled according to medical coding of review of systems (ROS)
Exclusion Criteria:
Tobacco smoking for at least 6 months before the study enrollment
- Participants with ill-fitting restorations in both upper first molars that affect the stability of the stent.
- Participants not following oral hygiene instructions.
- Participants on dental treatment during the study period.
- Participants with a history of drug administration
- Vulnerable group.
- Participants with long-term mouthwash administration.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
non tested comparative group
Er: YSGG laser tested group
Arm Description
two sealed new implants as a control
24 infected implants divided into four subgroups that will be decontaminated by Er: YSGG laser in various peri-implant defects
Outcomes
Primary Outcome Measures
visual inspection of the oral biofilm removal efficacy
evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology
Secondary Outcome Measures
Profilometer analysis of surface roughness changes
assess the morphological changes of implant surface after Er: YSGG laser therapy through Profilometer analysis
Full Information
NCT ID
NCT05137821
First Posted
October 1, 2021
Last Updated
November 16, 2021
Sponsor
Ain Shams University
1. Study Identification
Unique Protocol Identification Number
NCT05137821
Brief Title
Efficacy of Er: YSGG Laser in Treatment of Peri-implantitis
Official Title
Efficacy of Er: YSGG Laser on Oral Biofilm Removal From Implant Surface and Its Biological Response to Periodontal Tissues in Treatment of Peri-implantitis (An Ex Vivo Study)
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 2021 (Anticipated)
Primary Completion Date
January 2022 (Anticipated)
Study Completion Date
February 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
5. Study Description
Brief Summary
This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective.
To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.
Detailed Description
This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective.
To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.
The study was designed as an Ex Vivo study. Four periodontally and systemically healthy volunteers of both gender are included in this study for the formation of in vivo plaque biofilm. Each volunteer will wear a hard resin splint carrying six rough (machined implant; 3.3mm diameter, 8mm length) for 4 days to accumulate dental plaque naturally on the titanium surfaces of the implants.
Therefore, 24 implants will be assessed for Er: YSGG laser therapy in different bone defect simulators.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peri-Implantitis
Keywords
Er: YSGG laser therapy, Peri-Implantitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
two group control and test group test group divided into four subgroups
Masking
Investigator
Allocation
Randomized
Enrollment
4 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
non tested comparative group
Arm Type
Experimental
Arm Description
two sealed new implants as a control
Arm Title
Er: YSGG laser tested group
Arm Type
Experimental
Arm Description
24 infected implants divided into four subgroups that will be decontaminated by Er: YSGG laser in various peri-implant defects
Intervention Type
Device
Intervention Name(s)
Er: YSGG laser
Intervention Description
Er: YSGG laser decontamination of infected implant surfaces to simulate peri-implantitis therapy
Intervention Type
Other
Intervention Name(s)
no therapy
Intervention Description
new sealed implant without any surface treatment
Primary Outcome Measure Information:
Title
visual inspection of the oral biofilm removal efficacy
Description
evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Profilometer analysis of surface roughness changes
Description
assess the morphological changes of implant surface after Er: YSGG laser therapy through Profilometer analysis
Time Frame
1 month
Other Pre-specified Outcome Measures:
Title
biocompatibility test of the surface
Description
assess the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs)
Time Frame
2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Sex: female or male.
Age: 25 - 55 years.
Medically controlled according to medical coding of review of systems (ROS)
Exclusion Criteria:
Tobacco smoking for at least 6 months before the study enrollment
Participants with ill-fitting restorations in both upper first molars that affect the stability of the stent.
Participants not following oral hygiene instructions.
Participants on dental treatment during the study period.
Participants with a history of drug administration
Vulnerable group.
Participants with long-term mouthwash administration.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
alaa Hashim, Assistant lecturer
Phone
01003942056
Email
dralaa89@dent.asu.edu.eg
12. IPD Sharing Statement
Learn more about this trial
Efficacy of Er: YSGG Laser in Treatment of Peri-implantitis
We'll reach out to this number within 24 hrs